Первый опыт применения стандартизированной генотипической методики определения тропизма вич
Alexey E. Lopatukhin, Киреев Дмитрий Евгеньевич, А Н Поляков et al. · Клиническая лабораторная диагностика · 2013
The antagonists of co-receptor CCR5 are an ultimately new class of preparations to treat HIV-infection. The mechanism of action of the preparations of this class is in the selective binding with co-receptor CCR5. This process results in the prevention of penetration of HIV into cell. Before prescribing the CCR5 antagonists the detection of viral tropism has to be done. Recently, in Russia the genotype technique of tropism detection was registered which can be used in clinical practice. The present article describes first experience of application of the given technique to clinical samples. The high correlation was established while comparing with the results of reference laboratory.
Cited by 0 works.
Authors
- Alexey E. Lopatukhin
- Киреев Дмитрий Евгеньевич
- А Н Поляков
- Eugenij Bukin
- Rolf Kaiser
- Nadine Lübke
- Куевда Дмитрий Александрович
- German Alexandrovich Shipulin
References
- Development and Characterization of a Novel Single-Cycle Recombinant-Virus Assay To Determine Human Immunodeficiency Virus Type 1 Coreceptor Tropism
- Predicting HIV-1 coreceptor usage with sequence analysis.
- Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping
- Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group.
- Prediction of HIV-1 Coreceptor Usage (Tropism) by Sequence Analysis using a Genotypic Approach